Literature DB >> 19344282

Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy.

Erin R Steenblock1, Stephen H Wrzesinski, Richard A Flavell, Tarek M Fahmy.   

Abstract

BACKGROUND: Recent findings on T cells and dendritic cells have elucidated principles that can be used for a bottom-up approach to engineering artificial antigen presentation on synthetic substrates. OBJECTIVE/
METHODS: To compare the latest artificial antigen-presenting cell (aAPC) technology, focussing on acellular systems because they offer advantages such as easy tunability and rapid point-of-care application compared with cellular systems. We review acellular aAPC performance and discuss their promise for clinical applications. RESULTS/
CONCLUSION: Acellular aAPCs are a powerful alternative to natural-cell-based therapies, offering flexibility and modularity for incorporation oSf a variety of stimuli, hence increasing precision. Current technologies should adapt physiologically important signals within safe materials to more closely approximate their cellular counterparts. These constructs could be administered parenterally as APC replacements for active vaccines or used ex vivo for adoptive immunotherapy.

Mesh:

Substances:

Year:  2009        PMID: 19344282     DOI: 10.1517/14712590902849216

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  24 in total

1.  An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response.

Authors:  Erin R Steenblock; Tarek Fadel; Michael Labowsky; Jordan S Pober; Tarek M Fahmy
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

Review 2.  Biomimetic and synthetic interfaces to tune immune responses.

Authors:  Anusha Garapaty; Julie A Champion
Journal:  Biointerphases       Date:  2015-09-15       Impact factor: 2.456

Review 3.  Surface engineering for lymphocyte programming.

Authors:  Elana Ben-Akiva; Randall A Meyer; David R Wilson; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2017-05-10       Impact factor: 15.470

4.  Future opportunities in cancer nanotechnology--NCI strategic workshop report.

Authors:  Piotr Grodzinski; Dorothy Farrell
Journal:  Cancer Res       Date:  2014-01-10       Impact factor: 12.701

5.  Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity.

Authors:  Enping Hong; Ilana M Usiskin; Cristina Bergamaschi; Douglas J Hanlon; Richard L Edelson; Sune Justesen; George N Pavlakis; Richard A Flavell; Tarek M Fahmy
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

Review 6.  Nanoscale artificial antigen presenting cells for cancer immunotherapy.

Authors:  Kelly R Rhodes; Jordan J Green
Journal:  Mol Immunol       Date:  2018-03-07       Impact factor: 4.407

Review 7.  Biomimetic delivery with micro- and nanoparticles.

Authors:  Stephen C Balmert; Steven R Little
Journal:  Adv Mater       Date:  2012-04-23       Impact factor: 30.849

Review 8.  Artificial antigen-presenting cells for use in adoptive immunotherapy.

Authors:  Cameron J Turtle; Stanley R Riddell
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

9.  Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.

Authors:  Joel C Sunshine; Karlo Perica; Jonathan P Schneck; Jordan J Green
Journal:  Biomaterials       Date:  2013-10-05       Impact factor: 12.479

10.  An in silico analysis of nanoparticle/cell diffusive transfer: application to nano-artificial antigen-presenting cell:T-cell interaction.

Authors:  Michael Labowsky; Justin Lowenthal; Tarek M Fahmy
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.